(Q34059726)

English

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maurizio Cosimelli

object named as

M Cosimelli

1

0 references

object named as

F Izzo

19

0 references

Isabella Sperduti

object named as

I Sperduti

8

0 references

author name string

R Golfieri

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P P Cagol

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

L Carpanese

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

R Sciuto

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

C L Maini

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

R Mancini

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

G Pizzi

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M G Diodoro

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M Perrone

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

E Giampalma

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

B Angelelli

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

F Fiore

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

S Lastoria

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

S Bacchetti

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D Gasperini

17

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

O Geatti

18

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Italian Society of Locoregional Therapies in Oncology (SITILO)

20

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

13 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

324-331

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N99

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Radiotherapy for localized rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Modern multimodality approach to hepatic colorectal metastases: solutions and controversies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Epidemiology of colorectal liver metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Evidence-base guideline on management of colorectal liver metastases in the Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Surgical strategies for colorectal liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

5 July 2018

Sample size tables for exact single-stage phase II designs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Liver disease induced by radioembolization of liver tumors: description and possible risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605770

21 January 2018

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

28 October 2018

Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920024

28 October 2018

Epidemiology and management of liver metastases from colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20628388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605770

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34059726&oldid=2196185719"